Bayer takes €9.25 billion writedown Bayer took impairment charges of €9.25 billion and said the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher as ... Business • 03 Nov 20
Bayer makes progress in settlement talks over Roundup Bayer said today it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a ... Business • 25 May 20
Number of glyphosate plaintiffs jumps to 42,700 - Bayer Bayer said the number of US plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July, raising the stakes in ... Business • 30 Oct 19
Bayer facing 18,400 US cases over glyphosate German pharmaceutical giant Bayer has said it is now targetted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say ... Business • 30 Jul 19
US judge slashes Roundup jury award to $25.3m A federal judge has cut a damages award Bayer owed a California man who blamed Roundup weed killer for his cancer, to $25.27m from $80.27m. Business • 16 Jul 19
Bayer stock falls on $2 billion award in Roundup trial Shares in Bayer were down 5.9% today after a jury awarded more than $2 billion to a California couple in the largest US jury verdict ... Business • 14 May 19
Bayer gets Monsanto profit boost but legal burden grows German drug and farming supplies company Bayer has today posted a 45% gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto. Business • 25 Apr 19
Five things to know about Bayer and Monsanto The second cancer victim in a year to win a surprise victory against US pesticide maker Monsanto raises the prospect of a flood of similar ... Business • 20 Mar 19
Investors flee Bayer after second Roundup trial blow The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller ... Business • 20 Mar 19
France bans weed-killer after court ruling French authorities have banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into ... Europe • 15 Jan 19
US judge upholds Monsanto verdict but slashes award A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed ... World • 23 Oct 18
Bayer shares plunge 14% after Roundup cancer trial Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the ... Business • 13 Aug 18
Russian nod moves Bayer closer to Monsanto deal Russia's competition regulator FAS has approved Bayer's planned takeover of Monsanto, the German drugs and crop chemicals maker said, as it enters the home stretch ... Business • 20 Apr 18
Bayer reaches deal with US for approval to buy Monsanto The US Justice Department will allow German drugs and pesticides group Bayer to acquire Monsanto in a $62.5 billion deal, according to US media reports. Business • 10 Apr 18
Bayer wins EU approval for $62.5 billion Monsanto buy German conglomerate Bayer has today won EU competition approval for its $62.5 billion buy of US peer Monsanto, the latest in a trio of mega ... Business • 21 Mar 18
Bayer to win EU approval for $62 billion Monsanto deal German drug and crop chemicals maker Bayer is set to win conditional European Union competition approval for its $62.5 billion bid for the world's biggest ... Business • 28 Feb 18
BASF to buy seeds, herbicide businesses from Bayer BASF has agreed to buy significant parts of Bayer's seed and herbicide businesses for €5.9 billion in cash, the two companies said today. Business • 13 Oct 17
Monsanto profit tops expectations on soybean sales Seeds and agrochemicals company Monsanto, which is being bought by Germany's Bayer, reported a stronger-than-expected quarterly profit as record US and Brazilian soybean plantings lifted ... Business • 28 Jun 17
Monsanto posts better than expected jump in Q2 profit US seeds and agrochemicals company Monsanto today reported a better than expected quarterly profit, helped by strong demand for its soybean and corn seeds. Business • 05 Apr 17
Bayer confirms $66 billion takeover of Monsanto German drugs and crop chemicals company Bayer has confirmed that it has closed a deal to buy US seeds firm Monsanto for $66 billion. Business • 14 Sep 16
Bayer sweetens Monsanto bid as talks continue German pharmaceutical and crops manufacturer Bayer said its negotiations with Monsanto had advanced, and that it was now willing to offer over $65 billion to ... Business • 06 Sep 16
Monsanto calls Bayer's raised bid 'insufficient' US agrochemical giant Monsanto said today that an increased takeover bid from Germany's Bayer was still "insufficient," but that it remains open to talks to ... Business • 19 Jul 16
Bayer sweetens offer for hesitant Monsanto German drug and crop chemical group Bayer has announced details of a sweetened $64 billion bid for Monsanto as it tries to put the US ... Business • 15 Jul 16
Monsanto talks on 'alternative strategic options' Monsanto said it was in talks with Bayer's management and others regarding "alternative strategic options," a month after the US seed producer rejected the German ... Business • 29 Jun 16
Monsanto rejects Bayer bid as 'inadequate' US agribusiness giant Monsanto last night rejected the $62 billion takeover bid by Germany's Bayer as too low, but said it was willing to entertain ... Business • 25 May 16
